Editorial Archive Archives - Page 38 of 39 - Journal for Clinical Studies

Current Edition

Editorial Archive

Investigating Outbreaks of Novel Infectious Disease: An International Case Study

Investigating Outbreaks of Novel Infectious Disease: An International Case Study What can and should be done when lethal infections with epidemic or even pandemic po...

11 April 2013 Editorial Archive | Therapeutics V5 I2 (2)

Continue Reading →

Editorial Archive

Serious Adverse Events (SAE) Audit of an Oncology Clinical Trial

Serious Adverse Events (SAE) Audit of an Oncology Clinical Trial Clinical trials are the cornerstone of the development of new medicines. The safety profile of an inv...

11 April 2013 Editorial Archive | Therapeutics V5 I2 (2)

Continue Reading →

Editorial Archive

China – Part of the Critical Path in Drug Development in the 21st Century

China – Part of the Critical Path in Drug Development in the 21st Century In the last thirty years the United States has led the world in the field of R&D as it p...

10 April 2013 Editorial Archive | Market Report V5 I2 (2)

Continue Reading →

Editorial Archive

Tunisia – A Focus on the Clinical Trials Landscape

Tunisia - A Focus on the Clinical Trials Landscape Shifting clinical trials to North Africa is an up-to-date consideration for pharma development leaders for a multit...

10 April 2013 Editorial Archive | Market Report V5 I2 (2)

Continue Reading →

Editorial Archive

FDA Inspection Close Up – Using Strong Process Mapping and Gap Analysis

FDA Inspection Close Up - Using Strong Process Mapping and Gap Analysis An FDA regulatory inspection is an activity of verification. It serves to give the FDA the as...

10 April 2013 Editorial Archive | Regulatory V5 I2 (2)

Continue Reading →

Editorial Archive

Risk Mitigation and Due Diligence in Overcoming Lost to Follow-up [LTFU] Subjects in a Clinical Trial

Risk Mitigation and Due Diligence in Overcoming Lost to Follow-up [LTFU] Subjects in a Clinical Trial The term ‘lost to follow-up’ describes a patient who has premat...

10 April 2013 Editorial Archive | Regulatory V5 I2 (2)

Continue Reading →

Editorial Archive

Enhancement of Regulatory Procedures on Medicinal Products in Serbia – Patients Information Requirements

Enhancement of Regulatory Procedures on Medicinal Products in Serbia – Patients Information Requirements Providing reliable information on medicinal products to prof...

10 April 2013 Editorial Archive | Regulatory V5 I2 (2)

Continue Reading →

Editorial Archive

Health Economics and Multinational Randomised Controlled Trials

Health Economics and Multinational Randomised Controlled Trials Collecting clinical efficacy and safety data in multinational randomised controlled trials (MNRCTs) ha...

10 April 2013 Editorial Archive | Regulatory V5 I2 (2)

Continue Reading →

Editorial Archive

Improving Transition of Investigational Medicines in Alzheimer’s Disease From Phase I To Phase II

Improving Transition of Investigational Medicines in Alzheimer’s Disease From Phase I To Phase II In January 2012, the Obama administration’s Presidential advisory g...

15 February 2013 Editorial Archive | Special Features V5 I1 (2)

Continue Reading →

Editorial Archive

Cell-based Testing in Central Laboratories

Cell-based Testing in Central Laboratories Outsourcing is a growing trend in the pharmaceutical industry. Demands for central laboratory testing using complex cell-ba...

8 February 2013 Editorial Archive | Special Features V5 I1 (2)

Continue Reading →